Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1917 1
1925 2
1926 1
1933 2
1935 1
1937 1
1938 2
1940 1
1942 1
1943 1
1945 1
1946 2
1947 9
1948 9
1949 10
1950 16
1951 36
1952 25
1953 41
1954 25
1955 26
1956 27
1957 35
1958 22
1959 40
1960 34
1961 39
1962 49
1963 89
1964 127
1965 96
1966 80
1967 105
1968 144
1969 133
1970 157
1971 161
1972 193
1973 177
1974 216
1975 267
1976 283
1977 261
1978 283
1979 341
1980 337
1981 403
1982 400
1983 474
1984 522
1985 566
1986 564
1987 585
1988 639
1989 755
1990 753
1991 832
1992 851
1993 869
1994 935
1995 967
1996 845
1997 1002
1998 959
1999 898
2000 995
2001 1013
2002 948
2003 1106
2004 1132
2005 1138
2006 1191
2007 1279
2008 1338
2009 1365
2010 1436
2011 1490
2012 1566
2013 1570
2014 1617
2015 1656
2016 1667
2017 1698
2018 1643
2019 1622
2020 1801
2021 1876
2022 2027
2023 2113
2024 1826
2025 691

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51,241 results

Results by year

Filters applied: . Clear all
Page 1
Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R. Zafar A, et al. Med Res Rev. 2021 Mar;41(2):961-1021. doi: 10.1002/med.21750. Epub 2020 Nov 6. Med Res Rev. 2021. PMID: 33155698 Free PMC article. Review.
There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer-related mortality. Neuroblastomas exhibit genetic, morphological and clinical heterogeneity, …
There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is the most common pediatric solid tumor, an …
Management of Neuroblastoma in Pediatric Patients.
Croteau N, Nuchtern J, LaQuaglia MP. Croteau N, et al. Surg Oncol Clin N Am. 2021 Apr;30(2):291-304. doi: 10.1016/j.soc.2020.11.010. Epub 2021 Feb 10. Surg Oncol Clin N Am. 2021. PMID: 33706901 Review.
Surgeons caring for patients with neuroblastoma must be familiar with recent developments in assessing risk. In particular, the Children's Oncology Group, along with major international groups, uses the International Neuroblastoma Risk Group Staging System as a risk …
Surgeons caring for patients with neuroblastoma must be familiar with recent developments in assessing risk. In particular, the Child …
Advancing therapy for neuroblastoma.
Qiu B, Matthay KK. Qiu B, et al. Nat Rev Clin Oncol. 2022 Aug;19(8):515-533. doi: 10.1038/s41571-022-00643-z. Epub 2022 May 25. Nat Rev Clin Oncol. 2022. PMID: 35614230 Review.
Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course ranging from localized or spontaneously regressing to widely metastatic disease. Neuroblastomas recapitulate many of the features of sympathoadrenal development, which have been d …
Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course ranging from localized or spontaneously regres …
Recent advances in neuroblastoma.
Maris JM. Maris JM. N Engl J Med. 2010 Jun 10;362(23):2202-11. doi: 10.1056/NEJMra0804577. N Engl J Med. 2010. PMID: 20558371 Free PMC article. Review. No abstract available.
Origin and initiation mechanisms of neuroblastoma.
Tsubota S, Kadomatsu K. Tsubota S, et al. Cell Tissue Res. 2018 May;372(2):211-221. doi: 10.1007/s00441-018-2796-z. Epub 2018 Feb 14. Cell Tissue Res. 2018. PMID: 29445860 Review.
Extensive studies have revealed the molecular characteristics of human neuroblastomas, including abnormalities at genome, epigenome and transcriptome levels. However, neuroblastoma initiation mechanisms and even its origin are long-standing mysteries. ...A plausible …
Extensive studies have revealed the molecular characteristics of human neuroblastomas, including abnormalities at genome, epigenome a …
Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
Aygun N. Aygun N. Curr Pediatr Rev. 2018;14(2):73-90. doi: 10.2174/1573396314666180129101627. Curr Pediatr Rev. 2018. PMID: 29380702 Review.
Neuroblastoma usually occurs sporadically, but familial cases are also observed. ALK and PHOX2B germline mutations can cause hereditary neuroblastoma, while a common genetic variation in chromosome 6p22 is associated to sporadic neuroblastoma. ...MYCN is ampl …
Neuroblastoma usually occurs sporadically, but familial cases are also observed. ALK and PHOX2B germline mutations can cause heredita …
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.
Körber V, Stainczyk SA, Kurilov R, Henrich KO, Hero B, Brors B, Westermann F, Höfer T. Körber V, et al. Nat Genet. 2023 Apr;55(4):619-630. doi: 10.1038/s41588-023-01332-y. Epub 2023 Mar 27. Nat Genet. 2023. PMID: 36973454 Free PMC article.
Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. ...Thus, insight into neuroblastoma evolution may prospectively guide treatment decisions....
Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. .. …
Neuroblastoma.
Ishola TA, Chung DH. Ishola TA, et al. Surg Oncol. 2007 Nov;16(3):149-56. doi: 10.1016/j.suronc.2007.09.005. Epub 2007 Oct 31. Surg Oncol. 2007. PMID: 17976976 Review.
Neuroblastomas continue to remain a clinical challenge, despite advances in multimodal therapy. Currently, studies are aimed at novel targets for neuroblastoma directed toward poor prognostic indicators such as the MYCN oncogene and marked angiogenesis. ...
Neuroblastomas continue to remain a clinical challenge, despite advances in multimodal therapy. Currently, studies are aimed at novel …
Neuroblastoma.
Duckett JW, Koop CE. Duckett JW, et al. Urol Clin North Am. 1977 Jun;4(2):285-95. Urol Clin North Am. 1977. PMID: 331618 Review.
Neuroblastoma is the most common solid malignant tumor in children. The prognosis is poor, and despite varying chemotherapy and radiation regimens, its status has not been altered much in the past 20 years. Seventy per cent of the patients have abdominal neuroblastomas …
Neuroblastoma is the most common solid malignant tumor in children. The prognosis is poor, and despite varying chemotherapy and radia …
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Jansky S, Sharma AK, Körber V, Quintero A, Toprak UH, Wecht EM, Gartlgruber M, Greco A, Chomsky E, Grünewald TGP, Henrich KO, Tanay A, Herrmann C, Höfer T, Westermann F. Jansky S, et al. Nat Genet. 2021 May;53(5):683-693. doi: 10.1038/s41588-021-00806-1. Epub 2021 Mar 25. Nat Genet. 2021. PMID: 33767450
Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. However, the cellular origin of neuroblastoma has yet to be defined. Here we studied the single-cell transcriptomes of neuroblastomas and normal human developing adrenal glands a …
Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. However, the cellular origin of neuroblastoma …
51,241 results
You have reached the last available page of results. Please see the User Guide for more information.